6 February 2026
Full-Year Highlights Fourth-Quarter Highlights 2026 Guidance Woking, UK, February 5, 2026 – Linde plc (Nasdaq: LIN) today reported fourth-quarter 2025 net income of $1,530…
Summary of Unaudited Results Quarters $ million Full year Q4 2025 Q3 2025 Q4 2024 %¹ Reference 2025 2024 % 4,134 5,322 928…
4 February 2026
BlackRock American Income Trust plc LEI: 549300WWOCXSC241W468 Annual Report and Financial Statements 31 October 2025 Key highlights David Barron, the Chairman of the Company…
GlobalData Plc (“GlobalData” or “the Company”) Update on Move to the Main Market Further to previous announcements, GlobalData Plc (AIM: DATA), a leading provider…
GSK delivers strong 2025 performance and re-affirms long-term outlooks Sales, profit and earnings growth driven by strong Specialty Medicines performance 2025 Q4 2025 £m…
3 February 2026
PepsiCo Reports Fourth Quarter and Full-Year 2025 Results; Affirms 2026 Financial Outlook; Announces Annual Dividend Increase Reported (GAAP) Fourth Quarter and Full-Year 2025 Results…
2 February 2026
INTERIM RESULTS ANNOUNCEMENT Results for the twelve months ended 31 December 2025 Performance Highlights Net Asset Value At 31 December 2025 At 31 December…
Imfinzi perioperative regimen recommended for approval in the EU by CHMP for patients with early gastric and gastroesophageal cancers Recommendation based on MATTERHORN Phase III trial…